Categorized | Melanoma News

Melanoma Journal Articles for May 2018

Cancer Discovery

Dual MAPK/CDK Targeting in Melanoma: New Approaches, New Challenges

Ryan J. Sullivan

DOI: 10.1158/2159-8290.CD-18-0224 Published May 2018



Vemurafenib in Chinese patients with BRAFV600mutation–positive unresectable or metastatic melanoma: an open-label, multicenter phase I study

Lu Si, Xiaoshi Zhang, Zhen Xu, Qiudi Jiang, Lilian Bu, Xuan Wang, Lili Mao, Weijiang Zhang, Nicole Richie and Jun Guo

BMC Cancer201818:520

Received: 14 November 2016

Accepted: 12 March 2018

Published: 3 May 2018


Dove Press

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

Authors Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LAVeierød MB

Received 8 September 2017

Accepted for publication 27 January 2018

Published 9 May 2018 Volume 2018:10 Pages 537—548




Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas

Alexandra Giantini Larsen, BS Benjamin L Grannan, MD Christine K Lee, MD, PhDMatthew J Koch, MD Erik A Williams, MD Matthew P Frosch, MD, PhDDaniel P Cahill, MD, PhD

Journal of Neuropathology & Experimental Neurology, nly029,



Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, Angela Omilian, Wiam Bshara, Matthew Zibelman, Pooja Ghatalia, Konstantin Dragnev, Keisuke Shirai, Katherine G. Madden, Laura J. Tafe, Neel Shah, Deepa Kasuganti, Luis de la Cruz-Merino, Isabel Araujo, Yvonne Saenger, Margaret Bogardus, Miguel Villalona-Calero, Zuanel Diaz, Roger Day, Marcia Eisenberg, Steven M. Anderson, Igor Puzanov, Lorenzo Galluzzi, Mark Gardner and Marc S. Ernstoff

Journal for ImmunoTherapy of Cancer20186:32


Received: 13 February 2018

Accepted: 20 April 2018

Published: 9 May 2018



Improving the Propranolol Treatment of Melanoma—Reply

Silvia Benemei, MD1Pierangelo Geppetti, MD1Vincenzo De Giorgi, MD2

JAMA Oncol. Published online May 10, 2018.



The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

Michele Guida, Stefania Tommasi, Sabino Strippoli, Maria Iole Natalicchio, Simona De Summa, Rosamaria Pinto, Antonio Cramarossa, Anna Albano, Salvatore Pisconti, Michele Aieta, Ruggiero Ridolfi, Amalia Azzariti, Gabriella Guida, Vito Lorusso and Giusepe Colucci

BMC Cancer201818:552


Received: 8 July 2016

Accepted: 2 May 2018

Published: 10 May 2018


Dove Press

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Authors Tagliabue EGandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin CFargnoli MC, García-Borrón JC, Han J, Little JSera FRaimondi S

Received 26 October 2017

Accepted for publication 12 February 2018

Published 14 May 2018 Volume 2018:10 Pages 1143—1154






AMA Arch NeurPsych. 1952;68(2):266-275. doi:10.1001/archneurpsyc.1952.02320200104012


Cancer Research


NK cell editing mediates Epithelial to Mesenchymal Transition via phenotypic and proteomic changes in melanoma cell lines

Leticia Huergo Zapico, Monica Parodi, Claudia Cantoni, Chiara Lavarello, Juan L Fernández-Martínez, Andrea Petretto, Enrique J DeAndrés-Galiana, Mirna Balsamo, Alejandro López-Soto, Gabriella Pietra, Mattia Bugatti, Enrico Munari, Marcella Marconi, Maria Cristina Mingari, William Vermi, Lorenzo Moretta, Segundo Gonzalez and Massimo Vitale

DOI: 10.1158/0008-5472.CAN-17-1891


Dove Press

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions

Authors Brewington BY, Shao YF, Davidorf FH, Cebulla CM

Received 9 August 2017

Accepted for publication 20 February 2018

Published 17 May 2018 Volume 2018:12 Pages 925—934



Clinical Cancer Research

Playing the melanoma endgame

Jessica L.F. Teh and Andrew E. Aplin

DOI: 10.1158/1078-0432.CCR-18-0989

Accepted May 10, 2018



Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target

Muhammad Zaeem Noman,Jerome Paggetti,Etienne Moussay,Guy Berchem &Bassam Janji

Article: e1452583 | Received 08 Mar 2018, Accepted 10 Mar 2018, Accepted author version posted online: 15 Mar 2018, Published online: 25 Apr 2018


Journal of Oncology Practice

Management of In-Transit Melanoma: We Need Some High-Quality Data

David E. Gyorki

DOI: 10.1200/JOP.18.00215

Journal of Oncology Practice 14, no. 5 (May 1 2018) 302-303.


Advances in the systemic treatment of melanoma brain metastases 

I C Glitza Oliva G Schvartsman H Tawbi

Annals of Oncology, mdy185,

Published: 22 May 2018



Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases A Possible Variant of Locus Minoris Resistentiae

Marie Donaldson, BA1Joshua L. Owen, MD, PhD1Jennifer N. Choi, MD1,2

JAMA Dermatol. Published online May 23, 2018. doi:10.1001/jamadermatol.2018.0654



Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers

Dorota Hoja-?ukowicza, , Sabina SzwedaPiotr LaidlerbAnna Lity?skaa


Journal of Molecular Biology



Genome-Wide RNAi Screen Identify Melanoma-Associated Antigen Mageb3 Involved in X Chromosome Inactivation

Wei Li1Ru Hong1Lan-Tian Lai1Qiman Dong3Peiling Ni3Rosi Chelliah1Mehnaz Huq1Siti Nadirah Binte Ismail1Udita Chandola1Zhiwei Ang1Bingqing Lin1Xin Chen2Lingyi Chen3, , ,


Molecular Pharmaceutics

In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma

Abner A. MurrayChao WangSteven Fiering, and Nicole F. Steinmetz

DOI: 10.1021/acs.molpharmaceut.8b00316

Publication Date (Web): May 25, 2018


Cancer Letters

Pinocembrin induces ER stress mediated apoptosis and suppresses autophagy in melanoma cells

Yufei ZhengaKai WangbYuqi WuaYifan ChenaXi ChenaChenyue W. HucFuliang Hua, ,


Acta Physiologica

Cutaneous pH landscape as a facilitator of melanoma initiation and progression

Alexander Koch and Albrecht Schwab

First published: 26 May 2018


Advanced Functional Materials

Targeted Nanoparticle?Mediated Gene Therapy Mimics Oncolytic Virus for Effective Melanoma Treatment

Li Luo, Yuping Yang, Ting Du, Tianyi Kang, Meimei Xiong, Hao Cheng, Yu Liu, Yujiao Wu, Yang Li, Yuwen Chen, Qianqian Zhang, Xuan Liu, Xiawei Wei, Peng Mi, Zhigang She, et al.

First published: 28 May 2018



Annals of Oncology

Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists 


H A Haenssle C Fink R Schneiderbauer F Toberer T Buhl A Blum A Kalloo Hadj Hassen L Thomas A Enk

Annals of Oncology, mdy166,

Published:28 May 2018


Science Translational Medicine

Ironing out dedifferentiation in melanoma

Tríona Ní Chonghaile


Science Translational Medicine  30 May 2018:
Vol. 10, Issue 443, eaau0461
DOI: 10.1126/scitranslmed.aau0461


Clinical Cancer Research

Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome

Marie-Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana V. Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, Rene J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol S. Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein Tawbi, Michael K.K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard Royal, J.N. Cormier, Jennifer A. Wargo, Laszlo G. Radvanyi, Carlos A. Torres Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria and Chantale Bernatchez

DOI: 10.1158/1078-0432.CCR-17-3649




Gilhooley E, McKenna D, “Determination of the impact of melanoma surgical timing on survival using the National Cancer Database”, Journal of the American Academy of Dermatology (2018), doi: 10.1016/j.jaad.2018.03.061.


Brain Metastases from Primary Tumors, Volume 3

Epidemiology, Biology, and Therapy of Melanoma and Other Cancers

2016, Pages 185–196


Chapter 13 – Patients with Brain Metastases from Melanoma: Treatment with Surgery and Radiotherapy


Michael N. KhourySymeon MissiosNam D. TranPeter A. Forsyth


Dove Press

Melanoma treatment in review

Authors Domingues B, Lopes JMSoares P, Pópulo H

Received 30 January 2018

Accepted for publication 16 March 2018

Published 7 June 2018 Volume 2018:7 Pages 35—49